TABLE 1.
Clinical characteristics of patients at time of study
| Characteristic | Result for chronic HCV patient type (n):
|
|||
|---|---|---|---|---|
| NT (11) | NR (12) | R (12) | SVR (12) | |
| Mean age (yr) (range) | 54 (39-74) | 53 (40-62) | 45 (34-72) | 45 (32-61) |
| No. of patients with HCV genotype: | ||||
| 1 | 9 | 7 | 6 | 7 |
| 2 | 0 | 0 | 0 | 0 |
| 3 | 0 | 1 | 6 | 3 |
| 4 | 1 | 1 | 0 | 1 |
| NDa | 1 | 3 | 0 | 1 |
| No. of viremic patients | 11 | 12 | 0 | 0 |
| Mean ALTb (IU/ml) (range) | 89 (48-158) | 57 (48-163) | 33.5 (12-80) | 26 (9-85) |
| No. of patients receiving therapy regimen | ||||
| Ribavirin | 0 | 3 | 0 | 0 |
| IFN + ribavirin | 0 | 4 | 7 | 0 |
| PEG-IFNc + ribavirin | 0 | 5 | 3 | 0 |
| None (not treated) | 11 | 0 | 2 | 12 |
a
ND, not determined.
b
ALT, alanine amino transferase.
c
PEG-IFN, pegylated interferon.